Request for Covid-19 Impact Assessment of this Report
The United States Pneumococcal Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pneumococcal Vaccination market, reaching US$ million by the year 2028. As for the Europe Pneumococcal Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pneumococcal Vaccination players cover Pfizer, GSK, MSD, and Sanofipasteur, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
PPSV 23
PCV 7/13
PCV 10
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Child
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
WALVAX
Sinovac
Bio Kangtai
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccination Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pneumococcal Vaccination by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pneumococcal Vaccination by Country/Region, 2017, 2022 & 2028
2.2 Pneumococcal Vaccination Segment by Type
2.2.1 PPSV 23
2.2.2 PCV 7/13
2.2.3 PCV 10
2.3 Pneumococcal Vaccination Sales by Type
2.3.1 Global Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
2.3.2 Global Pneumococcal Vaccination Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pneumococcal Vaccination Sale Price by Type (2017-2022)
2.4 Pneumococcal Vaccination Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccination Sales by Application
2.5.1 Global Pneumococcal Vaccination Sale Market Share by Application (2017-2022)
2.5.2 Global Pneumococcal Vaccination Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pneumococcal Vaccination Sale Price by Application (2017-2022)
3 Global Pneumococcal Vaccination by Company
3.1 Global Pneumococcal Vaccination Breakdown Data by Company
3.1.1 Global Pneumococcal Vaccination Annual Sales by Company (2020-2022)
3.1.2 Global Pneumococcal Vaccination Sales Market Share by Company (2020-2022)
3.2 Global Pneumococcal Vaccination Annual Revenue by Company (2020-2022)
3.2.1 Global Pneumococcal Vaccination Revenue by Company (2020-2022)
3.2.2 Global Pneumococcal Vaccination Revenue Market Share by Company (2020-2022)
3.3 Global Pneumococcal Vaccination Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccination Product Location Distribution
3.4.2 Players Pneumococcal Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pneumococcal Vaccination by Geographic Region
4.1 World Historic Pneumococcal Vaccination Market Size by Geographic Region (2017-2022)
4.1.1 Global Pneumococcal Vaccination Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pneumococcal Vaccination Annual Revenue by Geographic Region
4.2 World Historic Pneumococcal Vaccination Market Size by Country/Region (2017-2022)
4.2.1 Global Pneumococcal Vaccination Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pneumococcal Vaccination Annual Revenue by Country/Region
4.3 Americas Pneumococcal Vaccination Sales Growth
4.4 APAC Pneumococcal Vaccination Sales Growth
4.5 Europe Pneumococcal Vaccination Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccination Sales Growth
5 Americas
5.1 Americas Pneumococcal Vaccination Sales by Country
5.1.1 Americas Pneumococcal Vaccination Sales by Country (2017-2022)
5.1.2 Americas Pneumococcal Vaccination Revenue by Country (2017-2022)
5.2 Americas Pneumococcal Vaccination Sales by Type
5.3 Americas Pneumococcal Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Vaccination Sales by Region
6.1.1 APAC Pneumococcal Vaccination Sales by Region (2017-2022)
6.1.2 APAC Pneumococcal Vaccination Revenue by Region (2017-2022)
6.2 APAC Pneumococcal Vaccination Sales by Type
6.3 APAC Pneumococcal Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pneumococcal Vaccination by Country
7.1.1 Europe Pneumococcal Vaccination Sales by Country (2017-2022)
7.1.2 Europe Pneumococcal Vaccination Revenue by Country (2017-2022)
7.2 Europe Pneumococcal Vaccination Sales by Type
7.3 Europe Pneumococcal Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Vaccination by Country
8.1.1 Middle East & Africa Pneumococcal Vaccination Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pneumococcal Vaccination Revenue by Country (2017-2022)
8.2 Middle East & Africa Pneumococcal Vaccination Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccination
10.3 Manufacturing Process Analysis of Pneumococcal Vaccination
10.4 Industry Chain Structure of Pneumococcal Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Vaccination Distributors
11.3 Pneumococcal Vaccination Customer
12 World Forecast Review for Pneumococcal Vaccination by Geographic Region
12.1 Global Pneumococcal Vaccination Market Size Forecast by Region
12.1.1 Global Pneumococcal Vaccination Forecast by Region (2023-2028)
12.1.2 Global Pneumococcal Vaccination Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pneumococcal Vaccination Forecast by Type
12.7 Global Pneumococcal Vaccination Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pneumococcal Vaccination Product Offered
13.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pneumococcal Vaccination Product Offered
13.2.3 GSK Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 MSD
13.3.1 MSD Company Information
13.3.2 MSD Pneumococcal Vaccination Product Offered
13.3.3 MSD Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 MSD Main Business Overview
13.3.5 MSD Latest Developments
13.4 Sanofipasteur
13.4.1 Sanofipasteur Company Information
13.4.2 Sanofipasteur Pneumococcal Vaccination Product Offered
13.4.3 Sanofipasteur Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofipasteur Main Business Overview
13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
13.5.1 CDIBP Company Information
13.5.2 CDIBP Pneumococcal Vaccination Product Offered
13.5.3 CDIBP Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CDIBP Main Business Overview
13.5.5 CDIBP Latest Developments
13.6 WALVAX
13.6.1 WALVAX Company Information
13.6.2 WALVAX Pneumococcal Vaccination Product Offered
13.6.3 WALVAX Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 WALVAX Main Business Overview
13.6.5 WALVAX Latest Developments
13.7 Sinovac
13.7.1 Sinovac Company Information
13.7.2 Sinovac Pneumococcal Vaccination Product Offered
13.7.3 Sinovac Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sinovac Main Business Overview
13.7.5 Sinovac Latest Developments
13.8 Bio Kangtai
13.8.1 Bio Kangtai Company Information
13.8.2 Bio Kangtai Pneumococcal Vaccination Product Offered
13.8.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bio Kangtai Main Business Overview
13.8.5 Bio Kangtai Latest Developments
14 Research Findings and Conclusion
Table 1. Pneumococcal Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pneumococcal Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 7. Global Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 8. Global Pneumococcal Vaccination Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pneumococcal Vaccination Revenue Market Share by Type (2017-2022)
Table 10. Global Pneumococcal Vaccination Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 12. Global Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 13. Global Pneumococcal Vaccination Revenue by Application (2017-2022)
Table 14. Global Pneumococcal Vaccination Revenue Market Share by Application (2017-2022)
Table 15. Global Pneumococcal Vaccination Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Pneumococcal Vaccination Sales by Company (2020-2022) & (Units)
Table 17. Global Pneumococcal Vaccination Sales Market Share by Company (2020-2022)
Table 18. Global Pneumococcal Vaccination Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pneumococcal Vaccination Revenue Market Share by Company (2020-2022)
Table 20. Global Pneumococcal Vaccination Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Pneumococcal Vaccination Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccination Products Offered
Table 23. Pneumococcal Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pneumococcal Vaccination Sales by Geographic Region (2017-2022) & (Units)
Table 27. Global Pneumococcal Vaccination Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pneumococcal Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pneumococcal Vaccination Sales by Country/Region (2017-2022) & (Units)
Table 31. Global Pneumococcal Vaccination Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pneumococcal Vaccination Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pneumococcal Vaccination Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 35. Americas Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 36. Americas Pneumococcal Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 38. Americas Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 39. Americas Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 40. Americas Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 41. Americas Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 42. APAC Pneumococcal Vaccination Sales by Region (2017-2022) & (Units)
Table 43. APAC Pneumococcal Vaccination Sales Market Share by Region (2017-2022)
Table 44. APAC Pneumococcal Vaccination Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pneumococcal Vaccination Revenue Market Share by Region (2017-2022)
Table 46. APAC Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 47. APAC Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 48. APAC Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 49. APAC Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 50. Europe Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 51. Europe Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 52. Europe Pneumococcal Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 54. Europe Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 55. Europe Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 56. Europe Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 57. Europe Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pneumococcal Vaccination Sales by Country (2017-2022) & (Units)
Table 59. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pneumococcal Vaccination Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pneumococcal Vaccination Sales by Type (2017-2022) & (Units)
Table 63. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pneumococcal Vaccination Sales by Application (2017-2022) & (Units)
Table 65. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccination
Table 67. Key Market Challenges & Risks of Pneumococcal Vaccination
Table 68. Key Industry Trends of Pneumococcal Vaccination
Table 69. Pneumococcal Vaccination Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pneumococcal Vaccination Distributors List
Table 72. Pneumococcal Vaccination Customer List
Table 73. Global Pneumococcal Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 74. Global Pneumococcal Vaccination Sales Market Forecast by Region
Table 75. Global Pneumococcal Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pneumococcal Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pneumococcal Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 78. Americas Pneumococcal Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pneumococcal Vaccination Sales Forecast by Region (2023-2028) & (Units)
Table 80. APAC Pneumococcal Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pneumococcal Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 82. Europe Pneumococcal Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pneumococcal Vaccination Sales Forecast by Country (2023-2028) & (Units)
Table 84. Middle East & Africa Pneumococcal Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pneumococcal Vaccination Sales Forecast by Type (2023-2028) & (Units)
Table 86. Global Pneumococcal Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pneumococcal Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pneumococcal Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pneumococcal Vaccination Sales Forecast by Application (2023-2028) & (Units)
Table 90. Global Pneumococcal Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pneumococcal Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pneumococcal Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Pneumococcal Vaccination Product Offered
Table 95. Pfizer Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. GSK Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. GSK Pneumococcal Vaccination Product Offered
Table 100. GSK Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GSK Main Business
Table 102. GSK Latest Developments
Table 103. MSD Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. MSD Pneumococcal Vaccination Product Offered
Table 105. MSD Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. MSD Main Business
Table 107. MSD Latest Developments
Table 108. Sanofipasteur Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofipasteur Pneumococcal Vaccination Product Offered
Table 110. Sanofipasteur Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Sanofipasteur Main Business
Table 112. Sanofipasteur Latest Developments
Table 113. CDIBP Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. CDIBP Pneumococcal Vaccination Product Offered
Table 115. CDIBP Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. CDIBP Main Business
Table 117. CDIBP Latest Developments
Table 118. WALVAX Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 119. WALVAX Pneumococcal Vaccination Product Offered
Table 120. WALVAX Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. WALVAX Main Business
Table 122. WALVAX Latest Developments
Table 123. Sinovac Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 124. Sinovac Pneumococcal Vaccination Product Offered
Table 125. Sinovac Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Sinovac Main Business
Table 127. Sinovac Latest Developments
Table 128. Bio Kangtai Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 129. Bio Kangtai Pneumococcal Vaccination Product Offered
Table 130. Bio Kangtai Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Bio Kangtai Main Business
Table 132. Bio Kangtai Latest Developments
List of Figures
Figure 1. Picture of Pneumococcal Vaccination
Figure 2. Pneumococcal Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccination Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Pneumococcal Vaccination Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pneumococcal Vaccination Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccination Sales Market Share by Type in 2021
Figure 13. Global Pneumococcal Vaccination Revenue Market Share by Type (2017-2022)
Figure 14. Pneumococcal Vaccination Consumed in Child
Figure 15. Global Pneumococcal Vaccination Market: Child (2017-2022) & (Units)
Figure 16. Pneumococcal Vaccination Consumed in Adult
Figure 17. Global Pneumococcal Vaccination Market: Adult (2017-2022) & (Units)
Figure 18. Global Pneumococcal Vaccination Sales Market Share by Application (2017-2022)
Figure 19. Global Pneumococcal Vaccination Revenue Market Share by Application in 2021
Figure 20. Pneumococcal Vaccination Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Pneumococcal Vaccination Revenue Market Share by Company in 2021
Figure 22. Global Pneumococcal Vaccination Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region in 2021
Figure 24. Global Pneumococcal Vaccination Sales Market Share by Region (2017-2022)
Figure 25. Global Pneumococcal Vaccination Revenue Market Share by Country/Region in 2021
Figure 26. Americas Pneumococcal Vaccination Sales 2017-2022 (Units)
Figure 27. Americas Pneumococcal Vaccination Revenue 2017-2022 ($ Millions)
Figure 28. APAC Pneumococcal Vaccination Sales 2017-2022 (Units)
Figure 29. APAC Pneumococcal Vaccination Revenue 2017-2022 ($ Millions)
Figure 30. Europe Pneumococcal Vaccination Sales 2017-2022 (Units)
Figure 31. Europe Pneumococcal Vaccination Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccination Sales 2017-2022 (Units)
Figure 33. Middle East & Africa Pneumococcal Vaccination Revenue 2017-2022 ($ Millions)
Figure 34. Americas Pneumococcal Vaccination Sales Market Share by Country in 2021
Figure 35. Americas Pneumococcal Vaccination Revenue Market Share by Country in 2021
Figure 36. United States Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Pneumococcal Vaccination Sales Market Share by Region in 2021
Figure 41. APAC Pneumococcal Vaccination Revenue Market Share by Regions in 2021
Figure 42. China Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Pneumococcal Vaccination Sales Market Share by Country in 2021
Figure 49. Europe Pneumococcal Vaccination Revenue Market Share by Country in 2021
Figure 50. Germany Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country in 2021
Figure 57. Egypt Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Pneumococcal Vaccination Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Pneumococcal Vaccination in 2021
Figure 63. Manufacturing Process Analysis of Pneumococcal Vaccination
Figure 64. Industry Chain Structure of Pneumococcal Vaccination
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...